Furthermore, in addition to alleviating the symptoms of lipid deposition in NASH models, TEC also were observed activating autophagy (increased LC3B expression), inhibiting pyroptosis and reducing the expression of inflammatory factor (IL-6, TNF-α, IL-10, IL-4, IL-17, and IL-1β) and TLR4, which is similar to other studies [23, 42, 43]. This evidence concerns the gene IL17A and metabolic dysfunction-associated steatohepatitis.